These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 894289)

  • 41. Continuous determination of 3H-labelled 3,4-dihydroxyphenethylamine (dopamine) synthesis and release in the cat caudate nucleus in vivo.
    Chéramy A; Glowinski J; Besson MJ; Gauchy C
    Biochem Soc Trans; 1976; 4(1):20-2. PubMed ID: 1001628
    [No Abstract]   [Full Text] [Related]  

  • 42. The in vivo release of acetylcholine from cat caudate nucleus after pharmacological and surgical manipulations of dopaminergic nigrostriatal neurons.
    Jones BE; Guyenet P; Chéramy A; Gauchy C; Glowinski J
    Brain Res; 1973 Dec; 64():355-69. PubMed ID: 4781346
    [No Abstract]   [Full Text] [Related]  

  • 43. Effects of the unilateral nigral application of baclofen on dopamine release in the two caudate nuclei of the cat.
    Chéramy A; Nieoullon A; Glowinski J
    Eur J Pharmacol; 1979 Sep; 58(2):133-40. PubMed ID: 499343
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nigro-striatal pathway: stimulation-evoked release of ( 3 H)dopamine from caudate nucleus.
    Voigtlander PF; Moore KE
    Brain Res; 1971 Dec; 35(2):580-3. PubMed ID: 5135554
    [No Abstract]   [Full Text] [Related]  

  • 45. Dopaminergic infllence in the basal ganglia: evidence for striatonigral feedback regulation.
    Bunney BS; Aghajanian GK
    Res Publ Assoc Res Nerv Ment Dis; 1976; 55():249-67. PubMed ID: 826996
    [No Abstract]   [Full Text] [Related]  

  • 46. Evidence for a direct action of amphetamine on dopamine metabolism in the rat substantia nigra in vivo.
    Argiolas A; Fadda F; Stefanini E; Gessa GL
    Naunyn Schmiedebergs Arch Pharmacol; 1978; 301(3):171-4. PubMed ID: 634376
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vivo release of [3H]GABA in cat caudate nucleus and substantia nigra. II. Involvement of different thalamic nuclei in the bilateral changes induced by a nigral application of muscimol.
    Kemel ML; Gauchy C; Glowinski J; Besson MJ
    Brain Res; 1984 Jun; 303(2):203-13. PubMed ID: 6331570
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vivo release of acetylcholinesterase in cat substantia nigra and caudate nucleus.
    Greenfield S; Cheramy A; Leviel V; Glowinski J
    Nature; 1980 Mar; 284(5754):355-7. PubMed ID: 7360271
    [No Abstract]   [Full Text] [Related]  

  • 49. Effects of neuroleptics on the nigroneostriatal and mesocortical dopaminergic systems.
    Glowinski J
    Res Publ Assoc Res Nerv Ment Dis; 1975; 54():233-46. PubMed ID: 769114
    [No Abstract]   [Full Text] [Related]  

  • 50. Control of 5-HT release in the caudate nucleus and the substantia nigra of the cat.
    Bourgoin S; Soubrié P; Artaud F; Reisine TD; Glowinski J
    J Physiol (Paris); 1981; 77(2-3):303-7. PubMed ID: 7288646
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sensory stimuli differentially affect in vivo nigral and striatal [3H]serotonin release in the cat.
    Reisine T; Soubrie P; Artaud F; Glowinski J
    Brain Res; 1982 Jan; 232(1):77-87. PubMed ID: 7055712
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cytochemical and electrophysiological studies of dopamine in the caudate nucleus.
    Siggins GR; Hoffer BJ; Bloom FE; Ungerstedt U
    Res Publ Assoc Res Nerv Ment Dis; 1976; 55():227-48. PubMed ID: 188086
    [No Abstract]   [Full Text] [Related]  

  • 53. Neurotensin-induced dopamine release in vivo and in vitro from substantia nigra and nucleus caudate.
    Faggin BM; Zubieta JK; Rezvani AH; Cubeddu LX
    J Pharmacol Exp Ther; 1990 Feb; 252(2):817-25. PubMed ID: 2138224
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vivo release of [3H]GABA in cat caudate nucleus and substantia nigra. I. Bilateral changes induced by a unilateral nigral application of muscimol.
    Kemel ML; Gauchy C; Romo R; Glowinski J; Besson MJ
    Brain Res; 1983 Aug; 272(2):331-40. PubMed ID: 6616207
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Short- and long-term changes in striatal and extrastriatal dopamine uptake sites in the MPTP-treated common marmoset.
    Gnanalingham KK; Milkowski NA; Smith LA; Hunter AJ; Jenner P; Marsden CD
    Eur J Pharmacol; 1995 Apr; 277(2-3):235-41. PubMed ID: 7493614
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of intracaudate drug injections on the striatal syndrome in reserpinized cats.
    David J; Kaul CL; Grewal RS
    Neuropharmacology; 1977 Mar; 16(3):179-89. PubMed ID: 840378
    [No Abstract]   [Full Text] [Related]  

  • 57. GABA in the thalamic motor nuclei modulates dopamine release from the two dopaminergic nigrostriatal pathways in the cat.
    Chesselet MF; Cheramy A; Romo R; Desban M; Glowinski J
    Exp Brain Res; 1983; 51(2):275-82. PubMed ID: 6617796
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evidence for a dopaminergic innervation of the cat lateral habenula: its role in controlling serotonin transmission in the basal ganglia.
    Reisine TD; Soubrié P; Ferron A; Blas C; Romo R; Glowinski J
    Brain Res; 1984 Aug; 308(2):281-8. PubMed ID: 6478209
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gabaergic processes involved in the control of dopamine release from nigrostriatal dopaminergic neurons in the cat.
    Chéramy A; Nieoullon A; Glowinski J
    Eur J Pharmacol; 1978 Apr; 48(3):281-95. PubMed ID: 639856
    [No Abstract]   [Full Text] [Related]  

  • 60. In vivo release of endogenously synthesized [3H]GABA from the cat substantia nigra and the pallido-entopeduncular nuclei.
    Gauchy C; Kemel ML; Glowinski J; Besson MJ
    Brain Res; 1980 Jul; 193(1):129-41. PubMed ID: 7378813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.